Latest News and Press Releases
Want to stay updated on the latest news?
-
--Advancing 11 clinical-stage assets across psychiatric conditions with Phase 2 data readouts in MDD and PTSD for each of its three lead candidates expected by mid-2023-- --Over $40 million in...